Top

Published in:

Open Access 01-12-2021 | Colorectal Cancer | Research article

Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects

Authors: P. G. Vaughan-Shaw, G. Grimes, J. P. Blackmur, M. Timofeeva, M. Walker, L. Y. Ooi, Victoria Svinti, Kevin Donnelly, F. V. N. Din, S. M. Farrington, M. G. Dunlop

Published in: BMC Medicine | Issue 1/2021

Abstract

Background

The risk for several common cancers is influenced by the transcriptomic landscape of the respective tissue-of-origin. Vitamin D influences in vitro gene expression and cancer cell growth. We sought to determine whether oral vitamin D induces beneficial gene expression effects in human rectal epithelium and identify biomarkers of response.

Methods

Blood and rectal mucosa was sampled from 191 human subjects and mucosa gene expression (HT12) correlated with plasma vitamin D (25-OHD) to identify differentially expressed genes. Fifty subjects were then administered 3200IU/day oral vitamin D3 and matched blood/mucosa resampled after 12 weeks. Transcriptomic changes (HT12/RNAseq) after supplementation were tested against the prioritised genes for gene-set and GO-process enrichment. To identify blood biomarkers of mucosal response, we derived receiver-operator curves and C-statistic (AUC) and tested biomarker reproducibility in an independent Supplementation Trial (BEST-D).

Results

Six hundred twenty-nine genes were associated with 25-OHD level (P < 0.01), highlighting 453 GO-term processes (FDR<0.05). In the whole intervention cohort, vitamin D supplementation enriched the prioritised mucosal gene-set (upregulated gene-set P < 1.0E−07; downregulated gene-set P < 2.6E−05) and corresponding GO terms (P = 2.90E−02), highlighting gene expression patterns consistent with anti-tumour effects. However, only 9 individual participants (18%) showed a significant response (NM gene-set enrichment P < 0.001) to supplementation. Expression changes in HIPK2 and PPP1CC expression served as blood biomarkers of mucosal transcriptomic response (AUC=0.84 [95%CI 0.66–1.00]) and replicated in BEST-D trial subjects (HIPK2 AUC=0.83 [95%CI 0.77–0.89]; PPP1CC AUC=0.91 [95%CI 0.86–0.95]).

Conclusions

Higher plasma 25-OHD correlates with rectal mucosa gene expression patterns consistent with anti-tumour effects, and this beneficial signature is induced by short-term vitamin D supplementation. Heterogenous gene expression responses to vitamin D may limit the ability of randomised trials to identify beneficial effects of supplementation on CRC risk. However, in the current study blood expression changes in HIPK2 and PPP1CC identify those participants with significant anti-tumour transcriptomic responses to supplementation in the rectum. These data provide compelling rationale for a trial of vitamin D and CRC prevention using easily assayed blood gene expression signatures as intermediate biomarkers of response.

Available only for authorised users

Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348(apr01 2):g2035. https://doi.org/10.1136/bmj.g2035.CrossRefPubMedPubMedCentral

Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76–89. https://doi.org/10.1016/S2213-8587(13)70165-7.CrossRefPubMed

Barry EL, Peacock JL, Rees JR, Bostick RM, Robertson DJ, Bresalier RS, et al. Vitamin D receptor genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3(5):628-35.

Hermann J, Eder P, Banasiewicz T, Matysiak K, Lykowska-Szuber L. Current management of anal fistulas in Crohn's disease. Prz Gastroenterol. 2015;10(2):83–8. https://doi.org/10.5114/pg.2015.49684.CrossRefPubMedPubMedCentral

Vaughan-Shaw PG, O'Sullivan F, Farrington SM, Theodoratou E, Campbell H, Dunlop MG, et al. The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis. Br J Cancer. 2017;116(8):1092–110. https://doi.org/10.1038/bjc.2017.44.CrossRefPubMedPubMedCentral

Vaughan-Shaw PG, Zgaga L, Ooi LY, Theodoratou E, Timofeeva M, Svinti V, et al. Low plasma vitamin D is associated with adverse colorectal cancer survival after surgical resection, independent of systemic inflammatory response. Gut. 2020;69(1):103–11. https://doi.org/10.1136/gutjnl-2018-317922.CrossRefPubMed

Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733–43. https://doi.org/10.1093/annonc/mdz059.CrossRefPubMedPubMedCentral

Vaughan-Shaw PG, Buijs LF, Blackmur JP, Theodoratou E, Zgaga L, Din FVN, et al. The effect of vitamin D supplementation on survival in patients with colorectal cancer: systematic review and meta-analysis of randomised controlled trials. Br J Cancer. 2020;123(11):1705–12. https://doi.org/10.1038/s41416-020-01060-8.CrossRefPubMedPubMedCentral

Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3(6):415–28. https://doi.org/10.1038/nrg816.CrossRefPubMed

10.

Bertucci F, Salas S, Eysteries S, Nasser V, Finetti P, Ginestier C, et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene. 2004;23(7):1377–91. https://doi.org/10.1038/sj.onc.1207262.CrossRefPubMed

11.

Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A. 1999;96(12):6745–50. https://doi.org/10.1073/pnas.96.12.6745.CrossRefPubMedPubMedCentral

12.

Chan SK, Griffith OL, Tai IT, Jones SJM. Meta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkers. Cancer Epidemiol Biomark Prev. 2008;17(3):543–52. https://doi.org/10.1158/1055-9965.EPI-07-2615.CrossRef

13.

Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, Aaltonen LA, et al. Gene expression in colorectal cancer. Cancer Res. 2002;62(15):4352–63.PubMed

14.

Dong X, Su YR, Barfield R, Bien SA, He Q, Harrison TA, et al. A general framework for functionally informed set-based analysis: application to a large-scale colorectal cancer study. PLoS Genet. 2020;16(8):e1008947. https://doi.org/10.1371/journal.pgen.1008947.CrossRefPubMedPubMedCentral

15.

Bosse Y, Li Z, Xia J, Manem V, Carreras-Torres R, Gabriel A, et al. Transcriptome-wide association study reveals candidate causal genes for lung cancer. Int J Cancer. 2020;146(7):1862–78. https://doi.org/10.1002/ijc.32771.CrossRefPubMed

16.

Fleet JC, DeSmet M, Johnson R, Li Y. Vitamin D and cancer: a review of molecular mechanisms. Biochem J. 2012;441(1):61–76. https://doi.org/10.1042/BJ20110744.CrossRefPubMed

17.

Protiva P, Pendyala S, Nelson C, Augenlicht LH, Lipkin M, Holt PR. Calcium and 1,25-dihydroxyvitamin D3 modulate genes of immune and inflammatory pathways in the human colon: a human crossover trial. Am J Clin Nutr. 2016;103(5):1224–31. https://doi.org/10.3945/ajcn.114.105304.CrossRefPubMedPubMedCentral

18.

Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin d from the institute of medicine: what clinicians need to know editorial comment. Obstet Gynecol Surv. 2011;66(6):356–7. https://doi.org/10.1097/OGX.0b013e31822c197a.CrossRef

19.

Seamans KM, Cashman KD. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr. 2009;89(6):1997s–2008s.CrossRefPubMed

20.

Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118–27. https://doi.org/10.1093/biostatistics/kxj037.CrossRefPubMed

21.

Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods. 2017;14(4):417–9. https://doi.org/10.1038/nmeth.4197.CrossRefPubMedPubMedCentral

22.

Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.CrossRefPubMed

23.

Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009;4(8):1184–91. https://doi.org/10.1038/nprot.2009.97.CrossRefPubMedPubMedCentral

24.

Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A, et al. BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005;21(16):3439–40. https://doi.org/10.1093/bioinformatics/bti525.CrossRefPubMed

25.

Wang TJ, Zhang F, Richards JB, Kestenbaum B, van Meurs JB, Berry D, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–8. https://doi.org/10.1016/S0140-6736(10)60588-0.CrossRefPubMedPubMedCentral

26.

Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56. https://doi.org/10.1016/j.gene.2004.05.014.CrossRefPubMed

27.

Staal A, van Wijnen AJ, Birkenhager JC, Pols HA, Prahl J, DeLuca H, et al. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol. 1996;10(11):1444–56. https://doi.org/10.1210/mend.10.11.8923469.CrossRefPubMed

28.

Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, Inoue Y, et al. The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res. 1999;14(2):240–7. https://doi.org/10.1359/jbmr.1999.14.2.240.CrossRefPubMed

29.

R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2013.

30.

Knox S, Harris J, Calton L, Wallace AM. A simple automated solid-phase extraction procedure for measurement of 25-hydroxyvitamin D3 and D2 by liquid chromatography-tandem mass spectrometry. Ann Clin Biochem. 2009;46(Pt 3):226–30. https://doi.org/10.1258/acb.2009.008206.CrossRefPubMed

31.

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https://doi.org/10.1093/nar/gkv007.CrossRefPubMedPubMedCentral

32.

Eden E, Navon R, Steinfeld I, Lipson D, Yakhini Z. GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists. BMC Bioinformatics. 2009;10(1):48. https://doi.org/10.1186/1471-2105-10-48.CrossRefPubMedPubMedCentral

33.

Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7. https://doi.org/10.1089/omi.2011.0118.CrossRefPubMedPubMedCentral

34.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–50. https://doi.org/10.1073/pnas.0506580102.CrossRefPubMedPubMedCentral

35.

Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, et al. Genomic response to vitamin D supplementation in the setting of a randomized, placebo-controlled trial. EBioMedicine. 2018;31:133–42. https://doi.org/10.1016/j.ebiom.2018.04.010.CrossRefPubMedPubMedCentral

36.

Yanagisawa Y, Takeoka M, Ehara T, Itano N, Miyagawa S, Taniguchi S. Reduction of Calponin h1 expression in human colon cancer blood vessels. Eur J Surg Oncol. 2008;34(5):531–7. https://doi.org/10.1016/j.ejso.2007.05.010.CrossRefPubMed

37.

Sandberg TP, Oosting J, van Pelt GW, Mesker WE, Tollenaar R, Morreau H. Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content. Oncotarget. 2018;9(59):31502–15. https://doi.org/10.18632/oncotarget.25845.CrossRefPubMedPubMedCentral

38.

Xue J, Ge X, Zhao W, Xue L, Dai C, Lin F, et al. PIPKIgamma regulates CCL2 expression in colorectal cancer by activating AKT-STAT3 signaling. J Immunol Res. 2019;2019:3690561.CrossRefPubMedPubMedCentral

39.

Lo PK, Lee JS, Liang X, Han L, Mori T, Fackler MJ, et al. Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer. Cancer Res. 2010;70(14):6047–58. https://doi.org/10.1158/0008-5472.CAN-10-1576.CrossRefPubMedPubMedCentral

40.

Kops GJ, Medema RH, Glassford J, Essers MA, Dijkers PF, Coffer PJ, et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol. 2002;22(7):2025–36. https://doi.org/10.1128/MCB.22.7.2025-2036.2002.CrossRefPubMedPubMedCentral

41.

Sung JC, McCarthy S, Turner J, Li CG, Yeatman TJ. The NBL1 tumor suppressor gene is downregulated in colon cancer by promoter methylation. J Am Coll Surg. 2006;199(3):S92.CrossRef

42.

Romano G, Santi L, Bianco MR, Giuffre MR, Pettinato M, Bugarin C, et al. The TGF-beta pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells. Oncotarget. 2016;7(16):22077–91. https://doi.org/10.18632/oncotarget.7895.CrossRefPubMedPubMedCentral

43.

Visuttijai K, Pettersson J, Mehrbani Azar Y, van den Bout I, Orndal C, Marcickiewicz J, et al. Lowered expression of tumor suppressor candidate MYO1C stimulates cell proliferation, suppresses cell adhesion and activates AKT. PLoS One. 2016;11(10):e0164063. https://doi.org/10.1371/journal.pone.0164063.CrossRefPubMedPubMedCentral

44.

Ha TK, Her NG, Lee MG, Ryu BK, Lee JH, Han J, et al. Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res. 2012;72(16):4097–109. https://doi.org/10.1158/0008-5472.CAN-12-0448.CrossRefPubMed

45.

Badiola I, Olaso E, Crende O, Friedman SL, Vidal-Vanaclocha F. Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis. Gut. 2012;61(10):1465–72. https://doi.org/10.1136/gutjnl-2011-300810.CrossRefPubMed

46.

Boulagnon-Rombi C, Schneider C, Leandri C, Jeanne A, Grybek V, Bressenot AM, et al. LRP1 expression in colon cancer predicts clinical outcome. Oncotarget. 2018;9(10):8849–69. https://doi.org/10.18632/oncotarget.24225.CrossRefPubMedPubMedCentral

47.

Wu JB, Sarmiento AL, Fiset PO, Lazaris A, Metrakos P, Petrillo S, et al. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis. World J Gastroenterol. 2019;25(26):3408–25. https://doi.org/10.3748/wjg.v25.i26.3408.CrossRefPubMedPubMedCentral

48.

Dasgupta N, Kumar Thakur B, Chakraborty A, Das S. Butyrate-induced in vitro colonocyte differentiation network model identifies ITGB1, SYK, CDKN2A, CHAF1A, and LRP1 as the prognostic markers for colorectal cancer recurrence. Nutr Cancer. 2019;71(2):257–71. https://doi.org/10.1080/01635581.2018.1540715.CrossRefPubMed

49.

Jiang H, Dong L, Gong F, Gu Y, Zhang H, Fan D, et al. Inflammatory genes are novel prognostic biomarkers for colorectal cancer. Int J Mol Med. 2018;42(1):368–80. https://doi.org/10.3892/ijmm.2018.3631.CrossRefPubMedPubMedCentral

50.

Luque-Garcia JL, Martinez-Torrecuadrada JL, Epifano C, Canamero M, Babel I, Casal JI. Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis. Proteomics. 2010;10(5):940–52. https://doi.org/10.1002/pmic.200900441.CrossRefPubMed

51.

Nakajima H, Koizumi K, Tanaka T, Ishigaki Y, Yoshitake Y, Yonekura H, et al. Loss of HITS (FAM107B) expression in cancers of multiple organs: tissue microarray analysis. Int J Oncol. 2012;41(4):1347–57. https://doi.org/10.3892/ijo.2012.1550.CrossRefPubMed

52.

Slattery ML, Lundgreen A, Wolff RK. MAP kinase genes and colon and rectal cancer. Carcinogenesis. 2012;33(12):2398–408. https://doi.org/10.1093/carcin/bgs305.CrossRefPubMedPubMedCentral

53.

Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol. 2005;23(9):1826–38. https://doi.org/10.1200/JCO.2005.00.406.CrossRefPubMed

54.

Slattery ML, Lundgreen A, Bondurant KL, Wolff RK. Tumor necrosis factor-related genes and colon and rectal cancer. Int J Mol Epidemiol Genet. 2011;2(4):328–38.PubMedPubMedCentral

55.

Meulmeester E, Jochemsen AG. p53: a guide to apoptosis. Curr Cancer Drug Targets. 2008;8(2):87–97. https://doi.org/10.2174/156800908783769337.CrossRefPubMed

56.

Ju YT, Kwag SJ, Park HJ, Jung EJ, Jeong CY, Jeong SH, et al. Decreased expression of heat shock protein 20 in colorectal cancer and its implication in tumorigenesis. J Cell Biochem. 2015;116(2):277–86. https://doi.org/10.1002/jcb.24966.CrossRefPubMed

57.

Kim J, Takeuchi H, Lam ST, Turner RR, Wang HJ, Kuo C, et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol. 2005;23(12):2744–53. https://doi.org/10.1200/JCO.2005.07.078.CrossRefPubMed

58.

Zhou J, Liu M, Zhai Y, Xie W. The antiapoptotic role of pregnane X receptor in human colon cancer cells. Mol Endocrinol. 2008;22(4):868–80. https://doi.org/10.1210/me.2007-0197.CrossRefPubMed

59.

Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007;81(5):1084–97. https://doi.org/10.1086/521987.CrossRefPubMedPubMedCentral

60.

Puca R, Nardinocchi L, Givol D, D'Orazi G. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. Oncogene. 2010;29(31):4378–87. https://doi.org/10.1038/onc.2010.183.CrossRefPubMed

61.

Kou Y, Zhang S, Chen X, Hu S. Gene expression profile analysis of colorectal cancer to investigate potential mechanisms using bioinformatics. Onco Targets Ther. 2015;8:745–52. https://doi.org/10.2147/OTT.S78974.CrossRefPubMedPubMedCentral

62.

Zhou T, Lin W, Zhu Q, Renaud H, Liu X, Li R, et al. The role of PEG3 in the occurrence and prognosis of colon cancer. Onco Targets Ther. 2019;12:6001–12. https://doi.org/10.2147/OTT.S208060.CrossRefPubMedPubMedCentral

63.

Zhou HM, Fang YY, Weinberger PM, Ding LL, Cowell JK, Hudson FZ, et al. Transgelin increases metastatic potential of colorectal cancer cells in vivo and alters expression of genes involved in cell motility. BMC Cancer. 2016;16(1):55. https://doi.org/10.1186/s12885-016-2105-8.CrossRefPubMedPubMedCentral

64.

Galamb O, Kalmar A, Peterfia B, Csabai I, Bodor A, Ribli D, et al. Aberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancer. Epigenetics. 2016;11(8):588–602. https://doi.org/10.1080/15592294.2016.1190894.CrossRefPubMedPubMedCentral

65.

Bostick RM. Effects of supplemental vitamin D and calcium on normal colon tissue and circulating biomarkers of risk for colorectal neoplasms. J Steroid Biochem Mol Biol. 2015;148:86–95. https://doi.org/10.1016/j.jsbmb.2015.01.010.CrossRefPubMedPubMedCentral

66.

Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2018.

67.

Scragg R, Khaw KT, Toop L, Sluyter J, Lawes CMM, Waayer D, et al. Monthly high-dose vitamin D supplementation and cancer risk: a post hoc analysis of the vitamin D assessment randomized clinical trial. JAMA Oncol. 2018;4(11):e182178. https://doi.org/10.1001/jamaoncol.2018.2178.CrossRefPubMedPubMedCentral

68.

Chandler PD, Chen WY, Ajala ON, Hazra A, Cook N, Bubes V, et al. Effect of vitamin D3 supplements on development of advanced cancer: a secondary analysis of the VITAL randomized clinical trial. JAMA Netw Open. 2020;3(11):e2025850. https://doi.org/10.1001/jamanetworkopen.2020.25850.CrossRefPubMedPubMedCentral

69.

Baron JA, Barry EL, Mott LA, Rees JR, Sandler RS, Snover DC, et al. A trial of calcium and vitamin D for the prevention of colorectal adenomas. N Engl J Med. 2015;373(16):1519–30. https://doi.org/10.1056/NEJMoa1500409.CrossRefPubMedPubMedCentral

70.

Vaughan-Shaw PG, Zgaga L, Theodoratou E, Blackmur JP, Dunlop MG. Whether vitamin D supplementation protects against colorectal cancer risk remains an open question. Eur J Cancer. 2019;115:1–3. https://doi.org/10.1016/j.ejca.2019.03.024.CrossRefPubMed

71.

He Y, Timofeeva M, Farrington SM, Vaughan-Shaw P, Svinti V, Walker M, et al. Exploring causality in the association between circulating 25-hydroxyvitamin D and colorectal cancer risk: a large Mendelian randomisation study. BMC Med. 2018;16(1):142. https://doi.org/10.1186/s12916-018-1119-2.CrossRefPubMedPubMedCentral

72.

Cornish AJ, Law PJ, Timofeeva M, Palin K, Farrington SM, Palles C, et al. Modifiable pathways for colorectal cancer: a mendelian randomisation analysis. Lancet Gastroenterol Hepatol. 2020;5(1):55–62. https://doi.org/10.1016/S2468-1253(19)30294-8.CrossRefPubMed

73.

Wagner D, Dias AG, Schnabl K, Van der Kwast T, Vieth R. Determination of 1,25-dihydroxyvitamin D concentrations in human colon tissues and matched serum samples. Anticancer Res. 2012;32(1):259–63.PubMed

74.

Ryynanen J, Neme A, Tuomainen TP, Virtanen JK, Voutilainen S, Nurmi T, et al. Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Mol Nutr Food Res. 2014;58(10):2036–45. https://doi.org/10.1002/mnfr.201400291.CrossRefPubMed

75.

Gerke AK, Pezzulo AA, Tang F, Cavanaugh JE, Bair TB, Phillips E, et al. Effects of vitamin D supplementation on alveolar macrophage gene expression: preliminary results of a randomized, controlled trial. Multidiscip Respir Med. 2014;9(1):18. https://doi.org/10.1186/2049-6958-9-18.CrossRefPubMedPubMedCentral

76.

Hossein-nezhad A, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8(3):e58725. https://doi.org/10.1371/journal.pone.0058725.CrossRefPubMedPubMedCentral

77.

Saksa N, Neme A, Ryynanen J, Uusitupa M, de Mello VD, Voutilainen S, et al. Dissecting high from low responders in a vitamin D3 intervention study. J Steroid Biochem Mol Biol. 2015;148:275–82. https://doi.org/10.1016/j.jsbmb.2014.11.012.CrossRefPubMed

78.

Buckmire M, Parquet G, Seeburger JL, Fukuchi SG, Rolandelli RH. Effect of bowel preparation and a fiber-free liquid diet on expression of transforming growth factor and procollagen in colonic tissue preoperatively and postoperatively. Dis Colon Rectum. 1998;41(10):1273–80. https://doi.org/10.1007/BF02258228.CrossRefPubMed

79.

Vaughan Shaw PG, Grimes G, Dunlop MG: Scottish Colorectal Cancer Vitamin D Intervention Study (SCoViDS). GEO. 2021 https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?&acc=GSE157982.

Title: Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects
Authors: P. G. Vaughan-Shaw
G. Grimes
J. P. Blackmur
M. Timofeeva
M. Walker
L. Y. Ooi
Victoria Svinti
Kevin Donnelly
F. V. N. Din
S. M. Farrington
M. G. Dunlop
Publication date: 01-12-2021
Publisher: BioMed Central
Keywords: Colorectal Cancer
Colorectal Cancer
Biomarkers
Published in: BMC Medicine / Issue 1/2021
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/s12916-021-02044-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Oral vitamin D supplementation induces transcriptomic changes in rectal mucosa that are linked to anti-tumour effects

Abstract

Background

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Investigating the relationships between unfavourable habitual sleep and metabolomic traits: evidence from multi-cohort multivariable regression and Mendelian randomization analyses

Diagnostic accuracy of pooling urine, anorectal, and oropharyngeal specimens for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae: a systematic review and meta-analysis

Is transcranial direct current stimulation, alone or in combination with antidepressant medications or psychotherapies, effective in treating major depressive disorder? A systematic review and meta-analysis

Marked reduction in antibiotic usage following intensive malaria control in a cohort of Ugandan children

The effects of selected inhibitors on human fetal adrenal steroidogenesis differs under basal and ACTH-stimulated conditions

Falciparum but not vivax malaria increases the risk of hypertensive disorders of pregnancy in women followed prospectively from the first trimester